AbCellera Biologics Stock (NASDAQ: ABCL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 25.00 / 1.91M |
Day Range | - - - |
52 Wk Range | 2.34 - 6.06 |
Market Cap | $786.76M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 7.74% |
Days to Cover | 8.2 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AbCellera Biologics (NASDAQ:ABCL) through any online brokerage.
Other companies in AbCellera Biologics’s space includes: 10x Genomics (NASDAQ:TXG), BioLife Solns (NASDAQ:BLFS), Sotera Health (NASDAQ:SHC), Quanterix (NASDAQ:QTRX) and ChromaDex (NASDAQ:CDXC).
AbCellera Biologics has a consensus price target of $21.67.
The stock price for AbCellera Biologics (NASDAQ: ABCL) is $2.67 last updated September 20, 2024 at 6:02 PM EDT.
There are no upcoming dividends for AbCellera Biologics.
AbCellera Biologics’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for AbCellera Biologics.
AbCellera Biologics is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.